Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Updated Analysis of the ELIANA Clinical Trial

被引:0
|
作者
Grupp, Stephan A. [1 ]
Maude, Shannon L. [1 ]
Rives, Susana [2 ]
Baruchel, Andre [3 ]
Boyer, Michael [4 ]
Bittencourt, Henrique [5 ]
Bader, Peter [6 ]
Buchner, Jochen [7 ]
Laetsch, Theodore W. [8 ,9 ]
Stefanski, Heather [10 ]
Myers, Gary Douglas [11 ]
Qayed, Muna [12 ]
Pulsipher, Michael A. [13 ]
De Moerloose, Barbara [14 ]
Yanik, Gregory A. [15 ]
Davis, Kara L. [16 ]
Martin, Paul L. [17 ]
Nemecek, Eneida R. [18 ]
Peters, Christina [19 ]
Krueger, Joerg [20 ]
Balduzzi, Adriana, Sr. [21 ,22 ]
Boissel, Nicolas [23 ]
Mechinaud, Francoise [24 ]
Leung, Mimi [25 ]
Eldjerou, Lamis [25 ]
Bleickardt, Eric [25 ]
Mueller, Karen Thudium [26 ]
Hiramatsu, Hidefumi [27 ]
机构
[1] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
[2] Hosp St Joan de Deu Barcelona, Dept Hematol & Oncol, Barcelona, Spain
[3] Hop St Louis, Dept Pediat, Paris, France
[4] Univ Utah, Blood & Marrow Transplant Program, Div Hematol & Hematol Malignancies, Huntsman Canc Inst, Salt Lake City, UT USA
[5] Hosp Clin, Belo Horizonte, MG, Brazil
[6] Klin Kinder & Jugendmed, Stem Cell Transplantat & Immunol, Frankfurt, Germany
[7] Oslo Univ Hosp, Dept Pediat Hematol & Oncol, Oslo, Norway
[8] Univ Texas Southwestern Med Ctr, Dallas, TX USA
[9] Childrens Hlth, Pauline Allen Gill Ctr Canc & Blood Disorders, Dallas, TX USA
[10] Univ Minnesota, Pediat Blood & Marrow Transplantat, Minneapolis, MN USA
[11] Childrens Mercy Hosp, Kansas City, MO 64108 USA
[12] Emory Univ, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA
[13] Childrens Hosp Los Angeles, Div Hematol Oncol & Blood & Marrow Transplantat, Los Angeles, CA 90027 USA
[14] Ghent Univ Hosp, Pediat Hematol Oncol & Stem Cell Transplantat, Ghent, Belgium
[15] Univ Michigan, Blood & Marrow Transplantat Program, Ann Arbor, MI 48109 USA
[16] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA
[17] Duke Univ, Med Ctr, Pediat Blood & Marrow Transplantat, Durham, NC USA
[18] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[19] St Anna Childrens Hosp, Stem Cell Transplantat Unit, Vienna, Austria
[20] Hosp Sick Children, Div Hematol Oncol BMT, Toronto, ON, Canada
[21] San Gerardo Hosp, HSCT Pediat Unit, Monza, Italy
[22] San Gerardo Hosp, Lab Cell Therapy S Verri, Monza, Italy
[23] Hop St Louis Univ, Paris, France
[24] Royal Childrens Hosp, Childrens Canc Ctr, Melbourne, Vic, Australia
[25] Novartis Pharmaceut, E Hanover, NJ USA
[26] Novartis Inst BioMed Res, E Hanover, NJ USA
[27] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
170
引用
收藏
页数:2
相关论文
共 50 条
  • [21] CLOFARABINE FOLLOWED BY CYCLOPHOSPHAMIDE FOR TREATMENT OF RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULT PATIENTS
    Malato, A.
    Santoro, A.
    Felice, R.
    Turri, D.
    Magrin, S.
    Di Bella, R.
    Scime, R.
    Salemi, D.
    Acquaviva, F.
    Fabbiano, F.
    HAEMATOLOGICA, 2012, 97 : 490 - 490
  • [22] Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomibbased chemotherapy
    Zhao, Junmei
    Wang, Chao
    Song, Yongping
    Liu, Yuzhang
    Fang, Baijun
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2015, 8 : 211 - 214
  • [23] Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Arend v. Stackelberg
    Katja Jäschke
    Etienne Jousseaume
    Corinna Templin
    Ulli Jeratsch
    Daniela Kosmides
    Ingo Steffen
    Nicola Gökbuget
    Christina Peters
    Leukemia, 2023, 37 : 2346 - 2355
  • [24] Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
    Deepa Bhojwani
    Richard Sposto
    Nirali N. Shah
    Vilmarie Rodriguez
    Constance Yuan
    Maryalice Stetler-Stevenson
    Maureen M. O’Brien
    Jennifer L. McNeer
    Amrana Quereshi
    Aurelie Cabannes
    Paul Schlegel
    Claudia Rossig
    Luciano Dalla-Pozza
    Keith August
    Sarah Alexander
    Jean-Pierre Bourquin
    Michel Zwaan
    Elizabeth A. Raetz
    Mignon L. Loh
    Susan R. Rheingold
    Leukemia, 2019, 33 : 884 - 892
  • [25] Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
    Bhojwani, Deepa
    Sposto, Richard
    Shah, Nirali N.
    Rodriguez, Vilmarie
    Yuan, Constance
    Stetler-Stevenson, Maryalice
    O'Brien, Maureen M.
    McNeer, Jennifer L.
    Quereshi, Amrana
    Cabannes, Aurelie
    Schlegel, Paul
    Rossig, Claudia
    Dalla-Pozza, Luciano
    August, Keith
    Alexander, Sarah
    Bourquin, Jean-Pierre
    Zwaan, Michel
    Raetz, Elizabeth A.
    Loh, Mignon L.
    Rheingold, Susan R.
    LEUKEMIA, 2019, 33 (04) : 884 - 892
  • [26] Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    V. Stackelberg, Arend
    Jaeschke, Katja
    Jousseaume, Etienne
    Templin, Corinna
    Jeratsch, Ulli
    Kosmides, Daniela
    Steffen, Ingo
    Goekbuget, Nicola
    Peters, Christina
    LEUKEMIA, 2023, 37 (12) : 2346 - 2355
  • [27] Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia
    Paul, Shilpa
    Rausch, Caitlin R.
    Nasnas, Patrice E.
    Kantarjian, Hagop
    Jabbour, Elias J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (03) : 166 - 175
  • [28] FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
    O'Leary, Maura C.
    Lu, Xiaobin
    Huang, Ying
    Lin, Xue
    Mahmood, Iftekhar
    Przepiorka, Donna
    Gavin, Denise
    Lee, Shiowjen
    Liu, Ke
    George, Bindu
    Bryan, Wilson
    Theoret, Marc R.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2019, 25 (04) : 1142 - 1146
  • [29] Obesity Associates with Inferior Outcomes and Toxicity in Pediatric and Young Adult Patient with Relapsed/ Refractory B-Cell Acute Lymphoblastic Leukemia Treated with Commercially Manufactured Tisagenlecleucel
    Ross, Anthony J.
    Baggott, Christina
    Prabhu, Snehit
    Pacenta, Holly
    Philips, Christine
    Rossoff, Jenna
    Stefanski, Heather E.
    Talano, Julie
    Moskop, Amy
    Baumeister, Susanne H. C.
    Verneris, Michael R.
    Myers, Gary Douglas
    Karras, Nicole
    Qayed, Muna
    Hermiston, Michelle L.
    Satwani, Prakash
    Krupski, Christa
    Keating, Amy K.
    Wilcox, Rachel
    Fabrizio, Vanessa A.
    Chinnabhandar, Vasant
    Curran, Kevin J.
    Mackall, Crystal L.
    Laetsch, Theodore W.
    Althouse, Sandra K.
    Maude, Shannon L.
    Henry, Curtis J.
    Schultz, Liora M.
    Skiles, Jodi L.
    BLOOD, 2022, 140 : 10419 - 10421
  • [30] FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia
    G. Specchia
    D. Pastore
    P. Carluccio
    A. Liso
    A. Mestice
    R. Rizzi
    L. Ciuffreda
    G. Pietrantuono
    V. Liso
    Annals of Hematology, 2005, 84 : 792 - 795